These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 32414689)
21. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. Moscoso M; García E; López R J Bacteriol; 2006 Nov; 188(22):7785-95. PubMed ID: 16936041 [TBL] [Abstract][Full Text] [Related]
22. The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm? Mowat E; Williams C; Jones B; McChlery S; Ramage G Med Mycol; 2009; 47 Suppl 1():S120-6. PubMed ID: 18654926 [TBL] [Abstract][Full Text] [Related]
23. Increased production of gliotoxin is related to the formation of biofilm by Aspergillus fumigatus: an immunological approach. Bugli F; Paroni Sterbini F; Cacaci M; Martini C; Lancellotti S; Stigliano E; Torelli R; Arena V; Caira M; Posteraro P; Sanguinetti M; Posteraro B Pathog Dis; 2014 Apr; 70(3):379-89. PubMed ID: 24623580 [TBL] [Abstract][Full Text] [Related]
24. Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza A virus infection. Pettigrew MM; Marks LR; Kong Y; Gent JF; Roche-Hakansson H; Hakansson AP Infect Immun; 2014 Nov; 82(11):4607-19. PubMed ID: 25135685 [TBL] [Abstract][Full Text] [Related]
25. Effect of serum components on biofilm formation by Aspergillus fumigatus and other Aspergillus species. Wuren T; Toyotome T; Yamaguchi M; Takahashi-Nakaguchi A; Muraosa Y; Yahiro M; Wang DN; Watanabe A; Taguchi H; Kamei K Jpn J Infect Dis; 2014; 67(3):172-9. PubMed ID: 24858605 [TBL] [Abstract][Full Text] [Related]
26. Growing and Characterizing Biofilms Formed by Streptococcus pneumoniae. Chao Y; Bergenfelz C; Hakansson AP Methods Mol Biol; 2019; 1968():147-171. PubMed ID: 30929213 [TBL] [Abstract][Full Text] [Related]
27. Aspergillus Biofilm In Vitro and In Vivo. Beauvais A; Latgé JP Microbiol Spectr; 2015 Aug; 3(4):. PubMed ID: 26350307 [TBL] [Abstract][Full Text] [Related]
28. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. Hall-Stoodley L; Nistico L; Sambanthamoorthy K; Dice B; Nguyen D; Mershon WJ; Johnson C; Hu FZ; Stoodley P; Ehrlich GD; Post JC BMC Microbiol; 2008 Oct; 8():173. PubMed ID: 18842140 [TBL] [Abstract][Full Text] [Related]
30. In vivo biofilm composition of Aspergillus fumigatus. Loussert C; Schmitt C; Prevost MC; Balloy V; Fadel E; Philippe B; Kauffmann-Lacroix C; Latgé JP; Beauvais A Cell Microbiol; 2010 Mar; 12(3):405-10. PubMed ID: 19889082 [TBL] [Abstract][Full Text] [Related]
31. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. Rajendran R; Mowat E; Jones B; Williams C; Ramage G Int J Antimicrob Agents; 2015 Sep; 46(3):342-5. PubMed ID: 25979638 [TBL] [Abstract][Full Text] [Related]
32. Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease. Trappetti C; Ogunniyi AD; Oggioni MR; Paton JC PLoS One; 2011; 6(5):e19844. PubMed ID: 21611130 [TBL] [Abstract][Full Text] [Related]
33. Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease. Chao Y; Marks LR; Pettigrew MM; Hakansson AP Front Cell Infect Microbiol; 2014; 4():194. PubMed ID: 25629011 [TBL] [Abstract][Full Text] [Related]
34. Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Rajendran R; Williams C; Lappin DF; Millington O; Martins M; Ramage G Eukaryot Cell; 2013 Mar; 12(3):420-9. PubMed ID: 23314962 [TBL] [Abstract][Full Text] [Related]
35. [BIOFILM FORMATION BY STREPTOCOCCUS PNEUMONIAE]. Mayanskiy AN; Chebotar IV; Lazareva AV; Mayanskiy NA Mol Gen Mikrobiol Virusol; 2015; 33(3):16-22. PubMed ID: 26665737 [TBL] [Abstract][Full Text] [Related]
36. Early biofilm formation on microtiter plates is not correlated with the invasive disease potential of Streptococcus pneumoniae. Lizcano A; Chin T; Sauer K; Tuomanen EI; Orihuela CJ Microb Pathog; 2010; 48(3-4):124-30. PubMed ID: 20096771 [TBL] [Abstract][Full Text] [Related]
37. Effect of 5-azacytidine on in vitro biofilm formation of Streptococcus pneumoniae. Yadav MK; Chae SW; Song JJ Microb Pathog; 2012; 53(5-6):219-26. PubMed ID: 22963864 [TBL] [Abstract][Full Text] [Related]
39. Streptococcus pneumoniae: the role of apoptosis in host defense and pathogenesis. Marriott HM; Dockrell DH Int J Biochem Cell Biol; 2006; 38(11):1848-54. PubMed ID: 16844403 [TBL] [Abstract][Full Text] [Related]
40. Dual Role of Hydrogen Peroxide as an Oxidant in Pneumococcal Pneumonia. Mraheil MA; Toque HA; La Pietra L; Hamacher J; Phanthok T; Verin A; Gonzales J; Su Y; Fulton D; Eaton DC; Chakraborty T; Lucas R Antioxid Redox Signal; 2021 Apr; 34(12):962-978. PubMed ID: 32283950 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]